Today

Celsius Holdings reported record first-quarter revenue and strong earnings, driven by recent acquisitions and robust brand performance.

Klarna Group plc reported a strong first quarter, returning to net profitability and showing significant growth across key financial metrics.

Pyxis Oncology reported a wider net loss for Q1 2026 and a cash runway into Q4 2026, while advancing its MICVO clinical program.

Circle Internet Group raised $222 million in a private presale of 740 million ARC tokens, introducing a new digital asset to its blockchain network.

Exzeo Group reported strong first-quarter 2026 financial results with increased revenue, net income, and managed premium.

MongoDB delivered strong fourth quarter and full year fiscal 2026 results, provided optimistic fiscal 2027 guidance, and announced key leadership transitions.

Focus Universal closed $10 million in convertible preferred stock private placements, introducing significant future dilution risk for common shareholders.

Upexi completed a $100 million private placement of common stock and pre-funded warrants, alongside issuing additional warrants to an asset manager, significantly increasing potential share dilution.

TransCode Therapeutics shareholders approved the issuance of common stock upon warrant exercise, including price adjustments and a cashless exercise feature, which could lead to significant future dilution.

TransCode Therapeutics shareholders will vote on a proposal to adjourn the special meeting if needed to solicit more proxies for another proposal.

Third Coast Bancshares shareholders approved the issuance of common stock required for its merger with Keystone Bancshares, Inc.

Lyra Therapeutics' stockholders approved a reverse stock split, which the Board then set at a 1-for-50 ratio, effective May 27, 2025.

Instructure Holdings has completed its all-cash acquisition by KKR and Dragoneer for $23.60 per share, leading to its delisting from the NYSE.

Dogwood Therapeutics completed a $12.5 million offering of common stock and warrants, with pre-funded warrants immediately exercisable, while also terminating its ATM program.

OLB Group completed a private placement of pre-funded and common warrants, generating $3.0 million in gross proceeds and creating substantial future share dilution.

Duos Technologies Group is raising approximately $55 million through an offering of common stock and pre-funded warrants, which will significantly increase its share count.

Worksport completed two registered direct offerings, issuing common stock and warrants for total gross proceeds of approximately $722,870, leading to immediate and potential future dilution.

Pyxis Oncology is raising $50 million through a private placement of common stock and warrants, with potential for an additional $64 million from warrant exercise.

Bone Biologics Corp completed a private offering of pre-funded warrants and common stock warrants, raising $2.7 million in net proceeds but creating substantial potential future dilution.

S&W Seed Company announced its decision to voluntarily delist its common stock from Nasdaq and deregister with the SEC, citing financial burdens and likely future non-compliance.